Experiences of Opioid Treatment Programs in Delivering Telemedicine Services During the COVID-19 Pandemic
Due to the COVID-19 pandemic, many opioid treatment programs (OTP) have had to rapidly transition from in-person care to telemedicine. Researchers at RAND will be conducting a qualitative study to explore providers’ experiences, the different modalities being offered, barriers encountered, and future plans. The study’s findings will inform the ongoing COVID-19 response and elicit lessons learned and policy recommendations for the future of OUD treatment.
- Webinar: OTP Clinician Perspectives on Methadone Service Delivery and the Use of Telemedicine During the COVID-19 Pandemic (FORE)
- Clinician perspectives on methadone service delivery and the use of telemedicine during the COVID-19 pandemic: A qualitative study (Journal of Substance Abuse Treatment)
- RAND Corporation Home Page